²úÆ·¹©Ó¦¸ñÁÐßÁàº

  • ·¢²¼ÈÕÆÚ£º2024-05-07
  • ÓÐЧÆÚÏÞ£º30Ìì
ºþ±±ºãÂÌÔ´¿Æ¼¼ÓÐÏÞ¹«Ë¾ VIP
249-427-6
C21H33N5O4S
451.5828

ÏêϸÐÅÏ¢
  • ;1-»·¼º»ù-3-{4-[2-(5-¼×»ùßÁàº-2-õ£°·)-ÒÒ»ù]±½»Çõ£}ëå;¸ñÁ¦ßÁàº;¸ñÁм×àº;ßÁ»Ç»·¼ºëå;
  • Glipizide
  • ;N-[2-[4-[[[(Cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]5-methylpyrazinecarboxamide;1-cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)ure;exylurea;Glipizibe;glipizide(usp);Glucotrol;GlucotrolXL;k4024;Melizide;N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-5-methylpyrazine-2-carboxamide;N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-piperazine-2-carboxamide;
  • InChI=1/C21H33N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,15,17,19,23-24H,2-6,11-14H2,1H3,(H,22,27)(H2,25,26,28)
  • 1.29g/cm3
  • 208-209¡ãC
  • methanol: 1.9 mg/mL
  • Íâ¹Û £º °×É«»òÀà°×É«½á¾§ÐÔ·ÛÄ©

ÃâÔðÉùÃ÷£ºÒÔÉÏËùչʾµÄÐÅÏ¢ÓÉÆóÒµ×ÔÐÐÌṩ£¬ÄÚÈݵÄÕæʵÐÔ¡¢×¼È·ÐԺͺϷ¨ÐÔÓÉ·¢²¼ÆóÒµ¸ºÔ𣬻¯¹¤Íø¶Ô´Ë²»³Ðµ£Èκα£Ö¤ÔðÈΡ£ÎÒÃÇÔ­ÔòÉϽ¨ÒéÄúÑ¡Ôñ»¯¹¤Íø¸ß¼¶»áÔ±»òVIP»áÔ±¡£